Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

Arcus Biosciences (RCUS) will participate in investor conferences in March 2024, including Leerink Global Biopharma Conference and Barclays Global Healthcare Conference. The company aims to showcase its differentiated molecules and combination therapies for cancer patients.

HAYWARD, Calif.--(BUSINESS WIRE)-- Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in the following upcoming investor conferences in March:

Leerink Global Biopharma Conference 2024
Date: Monday, March 11^th, 2024 at 4:00 p.m. ET
Location: Miami Beach, FL
Format: Fireside Chat

Barclays 26^th Annual Global Healthcare Conference
Date: Tuesday, March 12^th, 2024 at 2:35 p.m. ET
Location: Miami Beach, FL
Format: Fireside Chat

Live webcasts of the fireside chats and panel will be available by visiting the “Investors & Media” section of the Arcus Biosciences website at www.arcusbio.com. Replays will be available following each live event.

About Arcus Biosciences

Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer. In partnership with industry partners, patients and physicians around the world, Arcus is expediting the development of first- or best-in-class medicines against well-characterized biological targets and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. Founded in 2015, the company has expedited the development of multiple investigational medicines into clinical studies, including new combination approaches that target TIGIT, PD-1, the adenosine axis (CD73, dual A2a/A2b receptor and CD39), AXL and HIF-2a. For more information about Arcus Biosciences’ clinical and pre-clinical programs, please visit www.arcusbio.com or follow us on X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240227559746/en/

Investor Inquiries

Pia Eaves

VP of Investor Relations & Strategy

(617) 459-2006

peaves@arcusbio.com

Media Inquiries

Holli Kolkey

VP of Corporate Communications

(650) 922-1269

hkolkey@arcusbio.com

Source: Arcus Biosciences

FAQ

When will Arcus Biosciences (RCUS) participate in the Leerink Global Biopharma Conference?

Arcus Biosciences (RCUS) will participate in the Leerink Global Biopharma Conference on Monday, March 11th, 2024 at 4:00 p.m. ET.

Where will the Barclays 26th Annual Global Healthcare Conference take place?

The Barclays 26th Annual Global Healthcare Conference will be held in Miami Beach, FL.

How can investors access the webcasts of the fireside chats and panel discussions?

Investors can access the webcasts of the fireside chats and panel discussions by visiting the 'Investors & Media' section of the Arcus Biosciences website at www.arcusbio.com.